1Jemal A, Siegel R, Ward E, et al. Cancer Statistics [ J]. CA Cancer J Clin. 2007, 57(1) : 43-66.
2Panteleakou Z, Lembessis P, Sourla A, et al. Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance [ J ]. Mol Med, 2009, 15(3-4) : 101-114.
3Arya M, Bott SR, Shergill IS, et al. The metastatic cascade in prostate cancer[J]. Surg Oncol, 2006, 15(3) : 117-128.
4Mocellin S, Keilholz U, Rossi CR, et al. Circulating tumor cells: the leukemic phase of solid cancers [ J]. Trends Mol Med, 2006, 12(3): 130-139.
5Ashworth TR. A case of cance in which cells similar to those in the tumoura were seen in the blood after death[ J]. Arm Med J, 1869, 14(2) : 146-149.
6Alix-Panabires C, Vendrell JP, Pert6 O, et al. Detection and characterization of putative metastatic precursor cells in cancer patients[ J]. Clin Chem, 2007, 53(3): 537-539.
7Bjartell A. Circulating turnout ceils as surrogate biomarkers in castration-resistant prostate cancer Trials [ J ]. Eur Urol, 2011, 60(5) : 905-907.
9Kruger W, Datta C, Badbaran A, et al. Immunomagnetic tumor cell selection-implications for the detection of disseminated cancer cells [ J ]. Transfusion, 2000, 40 (12) : 1489-1493.
10Ellis W J, Pfitzenmaier J, Colli J, et al. Detection and isolation of prostate cancer cells from peripheral blood and bone marrow[J]. Urology, 2003, 61(2): 277-281.
2Soloway MS, Hardeman SW, Hickey D, et al. Stratification of patients with metastatic cancer based on extent of disease on initial bonesean[J]. Cancer, 1988, 61(1) : 195-202.
